Cutler Group LLC / CA - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,355
+13.6%
127,000
+30.8%
0.45%
-16.2%
Q2 2023$3,832
-30.4%
97,100
+29.1%
0.53%
-7.0%
Q1 2023$5,509
-25.3%
75,200
-4.9%
0.57%
-8.3%
Q4 2022$7,379
-89.6%
79,100
+2333.8%
0.62%
+12380.0%
Q3 2022$71,000
-72.3%
3,250
-74.0%
0.01%
-72.2%
Q2 2022$256,000
-20.2%
12,515
+30.7%
0.02%
+5.9%
Q1 2022$321,000
+126.1%
9,577
+184.2%
0.02%
+183.3%
Q4 2021$142,000
-14.5%
3,370
-15.8%
0.01%
-14.3%
Q3 2021$166,000
+9.9%
4,000
+117.4%
0.01%0.0%
Q2 2021$151,000
+32.5%
1,840
-12.4%
0.01%
+40.0%
Q1 2021$114,000
+235.3%
2,100
+10.5%
0.01%
+150.0%
Q4 2020$34,000
-91.1%
1,900
-79.6%
0.00%
-91.3%
Q3 2020$384,000
+114.5%
9,300
+39.2%
0.02%
+91.7%
Q2 2020$179,000
+20.9%
6,682
+67.0%
0.01%
+71.4%
Q1 2020$148,000
-12.9%
4,000
-2.6%
0.01%
-36.4%
Q4 2019$170,000
-25.4%
4,105
+5.1%
0.01%
-45.0%
Q3 2019$228,000
+33.3%
3,905
-76.5%
0.02%
+25.0%
Q2 2019$171,000
-69.8%
16,643
-24.0%
0.02%
-72.4%
Q1 2019$566,000
+209.3%
21,898
+3.3%
0.06%
+241.2%
Q4 2018$183,000
-71.8%
21,200
+15.4%
0.02%
-62.2%
Q3 2018$648,000
+97.6%
18,366
+166.2%
0.04%
+73.1%
Q2 2018$328,000
+4000.0%
6,900
+1161.4%
0.03%
Q1 2017$8,0000.0%5470.0%0.00%
Q4 2016$8,000
+33.3%
5470.0%0.00%
Q3 2016$6,0005470.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders